Attached files
file | filename |
---|---|
EX-32.1 - EX-32.1 - Krystal Biotech, Inc. | krys-ex321_9.htm |
EX-31.2 - EX-31.2 - Krystal Biotech, Inc. | krys-ex312_10.htm |
EX-31.1 - EX-31.1 - Krystal Biotech, Inc. | krys-ex311_11.htm |
EX-23.1 - EX-23.1 - Krystal Biotech, Inc. | krys-ex231_145.htm |
EX-10.1 - EX-10.1 - Krystal Biotech, Inc. | krys-ex101_226.htm |
10-K - 10-K - Krystal Biotech, Inc. | krys-10k_20171231.htm |
Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of Krystal Biotech, Inc. (the “Company”) on Form 10-K for the period ending December 31, 2017 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:
|
(1) |
The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
|
(2) |
The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company. |
Date: March 12, 2018 |
|
By: |
/s/ Antony A. Riley |
|
|
|
Antony A. Riley |
|
|
|
Chief Financial Officer (Principal Financial and Accounting Officer) |